66 related articles for article (PubMed ID: 12666108)
21. Gene therapy for ALS: A review.
Amado DA; Davidson BL
Mol Ther; 2021 Dec; 29(12):3345-3358. PubMed ID: 33839324
[TBL] [Abstract][Full Text] [Related]
22. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.
Gotkine M; Kviatcovsky D; Elinav E
Gut Microbes; 2020 Nov; 11(6):1833-1841. PubMed ID: 32501768
[TBL] [Abstract][Full Text] [Related]
23. Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.
Katyal N; Govindarajan R
Front Neurol; 2017; 8():521. PubMed ID: 29033893
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of Inflammation-Responsive Astrocytes from Glial Progenitors Generated from Human Induced Pluripotent Stem Cells.
Santos R; Vadodaria KC; Jaeger BN; Mei A; Lefcochilos-Fogelquist S; Mendes APD; Erikson G; Shokhirev M; Randolph-Moore L; Fredlender C; Dave S; Oefner R; Fitzpatrick C; Pena M; Barron JJ; Ku M; Denli AM; Kerman BE; Charnay P; Kelsoe JR; Marchetto MC; Gage FH
Stem Cell Reports; 2017 Jun; 8(6):1757-1769. PubMed ID: 28591655
[TBL] [Abstract][Full Text] [Related]
25. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS.
Lee J; Hyeon SJ; Im H; Ryu H; Kim Y; Ryu H
Exp Neurobiol; 2016 Oct; 25(5):233-240. PubMed ID: 27790057
[TBL] [Abstract][Full Text] [Related]
26. Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Medelin M; Rancic V; Cellot G; Laishram J; Veeraraghavan P; Rossi C; Muzio L; Sivilotti L; Ballerini L
J Physiol; 2016 Jul; 594(13):3827-40. PubMed ID: 27098371
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.
Mancuso R; del Valle J; Modol L; Martinez A; Granado-Serrano AB; Ramirez-Núñez O; Pallás M; Portero-Otin M; Osta R; Navarro X
Neurotherapeutics; 2014 Apr; 11(2):419-32. PubMed ID: 24414863
[TBL] [Abstract][Full Text] [Related]
28. Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS.
Jung MK; Kim KY; Lee NY; Kang YS; Hwang YJ; Kim Y; Sung JJ; McKee A; Kowall N; Lee J; Ryu H
Mol Neurobiol; 2013 Apr; 47(2):699-710. PubMed ID: 23180277
[TBL] [Abstract][Full Text] [Related]
29. Host induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche.
Xu L; Mahairaki V; Koliatsos VE
Regen Med; 2012 Nov; 7(6):785-97. PubMed ID: 23164079
[TBL] [Abstract][Full Text] [Related]
30. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease.
Zhao W; Varghese M; Vempati P; Dzhun A; Cheng A; Wang J; Lange D; Bilski A; Faravelli I; Pasinetti GM
PLoS One; 2012; 7(11):e49191. PubMed ID: 23145119
[TBL] [Abstract][Full Text] [Related]
31. Rodent models of TDP-43: recent advances.
Tsao W; Jeong YH; Lin S; Ling J; Price DL; Chiang PM; Wong PC
Brain Res; 2012 Jun; 1462():26-39. PubMed ID: 22608070
[TBL] [Abstract][Full Text] [Related]
32. The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome.
Krugner-Higby L; Caldwell S; Coyle K; Bush E; Atkinson R; Joers V
Comp Med; 2011 Feb; 61(1):31-8. PubMed ID: 21819679
[TBL] [Abstract][Full Text] [Related]
33. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.
Xu L; Shen P; Hazel T; Johe K; Koliatsos VE
Neurosci Lett; 2011 May; 494(3):222-6. PubMed ID: 21402124
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS.
Ryu H; Jeon GS; Cashman NR; Kowall NW; Lee J
Lab Invest; 2011 Mar; 91(3):342-52. PubMed ID: 21283077
[TBL] [Abstract][Full Text] [Related]
35. Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials.
Ludolph AC; Jesse S
Ther Adv Neurol Disord; 2009 Sep; 2(5):319-26. PubMed ID: 21180622
[TBL] [Abstract][Full Text] [Related]
36. TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology.
Wegorzewska I; Baloh RH
Neurodegener Dis; 2011; 8(4):262-74. PubMed ID: 21124004
[TBL] [Abstract][Full Text] [Related]
37. Current and emerging treatments for amyotrophic lateral sclerosis.
Zoccolella S; Santamato A; Lamberti P
Neuropsychiatr Dis Treat; 2009; 5():577-95. PubMed ID: 19966906
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice.
Lee J; Ryu H; Kowall NW
Biochem Biophys Res Commun; 2009 Sep; 387(1):202-6. PubMed ID: 19580782
[TBL] [Abstract][Full Text] [Related]
39. Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice.
Lee J; Ryu H; Kowall NW
Biochem Biophys Res Commun; 2009 Jul; 384(4):524-9. PubMed ID: 19427829
[TBL] [Abstract][Full Text] [Related]
40. Target identification for CNS diseases by transcriptional profiling.
Altar CA; Vawter MP; Ginsberg SD
Neuropsychopharmacology; 2009 Jan; 34(1):18-54. PubMed ID: 18923405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
